TW201637648A - 淚腺藥物遞輸系統 - Google Patents

淚腺藥物遞輸系統 Download PDF

Info

Publication number
TW201637648A
TW201637648A TW105110450A TW105110450A TW201637648A TW 201637648 A TW201637648 A TW 201637648A TW 105110450 A TW105110450 A TW 105110450A TW 105110450 A TW105110450 A TW 105110450A TW 201637648 A TW201637648 A TW 201637648A
Authority
TW
Taiwan
Prior art keywords
drug
lacrimal gland
percutaneous absorption
preparation
administration
Prior art date
Application number
TW105110450A
Other languages
English (en)
Chinese (zh)
Inventor
隱樹健二
淺田博之
宮崎達也
稻垣孝司
Original Assignee
參天製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 參天製藥股份有限公司 filed Critical 參天製藥股份有限公司
Publication of TW201637648A publication Critical patent/TW201637648A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
TW105110450A 2015-04-03 2016-04-01 淚腺藥物遞輸系統 TW201637648A (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015076890 2015-04-03

Publications (1)

Publication Number Publication Date
TW201637648A true TW201637648A (zh) 2016-11-01

Family

ID=57005012

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105110450A TW201637648A (zh) 2015-04-03 2016-04-01 淚腺藥物遞輸系統

Country Status (4)

Country Link
JP (1) JP2016196454A (es)
AR (1) AR104177A1 (es)
TW (1) TW201637648A (es)
WO (1) WO2016159351A1 (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111372564A (zh) * 2017-11-21 2020-07-03 艾克瑟罗视觉股份有限公司 用于治疗眼周分泌腺中或眼表上的异常发炎的组合物和方法
US11759472B2 (en) 2017-11-21 2023-09-19 Cs Pharmaceuticals Limited Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9102340D0 (sv) * 1991-08-13 1991-08-13 Astra Ab Pharmaceutical composition containing carbachol and othercholinergic substances
US20070053964A1 (en) * 2004-05-21 2007-03-08 Akiharu Isowaki Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist
ES2830024T3 (es) * 2007-10-19 2021-06-02 Novartis Ag Composiciones y métodos para el tratamiento del edema macular
CA2719453A1 (en) * 2008-03-26 2009-10-01 Eric Donnenfeld Methods for improving lid margin and tear film function and treatment of lid margin disease using tetracycline family antibiotics

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111372564A (zh) * 2017-11-21 2020-07-03 艾克瑟罗视觉股份有限公司 用于治疗眼周分泌腺中或眼表上的异常发炎的组合物和方法
US11759472B2 (en) 2017-11-21 2023-09-19 Cs Pharmaceuticals Limited Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface

Also Published As

Publication number Publication date
WO2016159351A1 (ja) 2016-10-06
JP2016196454A (ja) 2016-11-24
AR104177A1 (es) 2017-07-05

Similar Documents

Publication Publication Date Title
EP2493474B1 (en) Methods and compositions for sustained delivery of drugs
US9925201B2 (en) Compositions and treatment for eye diseases and disorders
JP6148664B2 (ja) 眼科治療
US20090318422A1 (en) Ophthalmic percutaneous absorption type preparation
US11759472B2 (en) Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface
US20230372360A1 (en) Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface
JP6861634B2 (ja) 眼疾患を処置するための組成物及び方法
TW201637648A (zh) 淚腺藥物遞輸系統
WO2016182032A1 (ja) アゾール系抗真菌薬の眼瞼皮膚への投与
JP2021095420A (ja) エピナスチン又はその塩を含有する水性医薬組成物
CN108348516B (zh) 外用剂
US20230174510A1 (en) N-acetylserotonin Derivatives as TrkB Activators and Uses Thereof
JP2005047909A (ja) ピペリジン誘導体を有効成分とする掻痒治療剤
WO2017062837A1 (en) Treatment of skin disorders by topical administration of vegf inhibitors
JPWO2013002196A1 (ja) 新規医薬組成物
WO2018017713A1 (en) Methods, compositions, and compounds for treatment of dermatological and ocular conditions
OA19529A (en) Compositions and methods for treating aberrant inflammation in peri - ocular secretory glands or at the ocular surface.
WO2005053672A1 (ja) シロミラストまたはその塩を有効成分とする掻痒治療剤
JP2005187458A (ja) シロミラストまたはその塩を有効成分とする掻痒治療剤